Does POLATUZUMAB VEDOTIN-PIIQ Cause Diffuse large b-cell lymphoma? 82 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Diffuse large b-cell lymphoma have been filed in association with POLATUZUMAB VEDOTIN-PIIQ. This represents 2.6% of all adverse event reports for POLATUZUMAB VEDOTIN-PIIQ.
82
Reports of Diffuse large b-cell lymphoma with POLATUZUMAB VEDOTIN-PIIQ
2.6%
of all POLATUZUMAB VEDOTIN-PIIQ reports
29
Deaths
2
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From POLATUZUMAB VEDOTIN-PIIQ?
Of the 82 reports, 29 (35.4%) resulted in death, 2 (2.4%) required hospitalization, and 11 (13.4%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POLATUZUMAB VEDOTIN-PIIQ. However, 82 reports have been filed with the FAERS database.
What Other Side Effects Does POLATUZUMAB VEDOTIN-PIIQ Cause?
Disease progression (753)
Off label use (484)
Death (367)
Covid-19 (202)
Neutropenia (160)
Pyrexia (119)
Drug ineffective (118)
No adverse event (109)
Blood lactate dehydrogenase increased (108)
Febrile neutropenia (107)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which POLATUZUMAB VEDOTIN-PIIQ Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
POLATUZUMAB VEDOTIN-PIIQ vs POLIDOCANOL
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM\SODIUM